• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤中双膦酸盐相关颌骨坏死的前瞻性观察研究:微生物群分析和细胞因子表达

Prospective Observational Study of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma: Microbiota Profiling and Cytokine Expression.

作者信息

Badros Ashraf Z, Meddeb Mariam, Weikel Dianna, Philip Sunita, Milliron Todd, Lapidus Rena, Hester Lisa, Goloubeva Olga, Meiller Timothy F, Mongodin Emmanuel F

机构信息

Greenebaum Cancer Center University of Maryland School of Medicine, Baltimore, MD, United States.

University of Maryland Dental School, Baltimore, MD, United States.

出版信息

Front Oncol. 2021 Jun 24;11:704722. doi: 10.3389/fonc.2021.704722. eCollection 2021.

DOI:10.3389/fonc.2021.704722
PMID:34249765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8263936/
Abstract

PURPOSE

Define incidence and risk factors of osteonecrosis of the jaw (ONJ) and explore oral microbial signatures and host immune response as reflected by cytokine changes in saliva and serum in multiple myeloma (MM) patients on bisphosphate (BP) therapy.

PATIENTS AND METHODS

A single center observational prospective study of MM patients (n = 110) on >2 years of BP, none had ONJ at enrollment. Patients were followed every 3 months for 18 months with clinical/dental examination and serial measurements of inflammatory cytokines, bone turnover markers, and angiogenic growth factors. Oral microbiota was characterized by sequencing of 16S rRNA gene from saliva.

RESULTS

Over the study period 14 patients (13%) developed BRONJ, at a median of 5.7 years (95% CI: 1.9-12.0) from MM diagnosis. Chronic periodontal disease was the main clinically observed risk factor. Oral microbial profiling revealed lower bacterial richness/diversity in BRONJ. , , and were abundant in controls; and were prevalent in BRONJ. In the saliva, at baseline patients who developed BRONJ had higher levels of MIP-1β; TNF-α and IL-6 compared to those without BRONJ, cytokine profile consistent with M-1 macrophage activation. In the serum, patients with BRONJ have significantly lower levels of TGF beta and VEGF over the study period.

CONCLUSION

Periodontal disease associated with low microbial diversity and predominance of invasive species with a proinflammatory cytokine profile leading to tissue damage and alteration of immunity seems to be the main culprit in pathogenesis of BRONJ.

摘要

目的

确定颌骨坏死(ONJ)的发病率和危险因素,并探索在接受双膦酸盐(BP)治疗的多发性骨髓瘤(MM)患者中,唾液和血清中细胞因子变化所反映的口腔微生物特征和宿主免疫反应。

患者与方法

对110例接受BP治疗超过2年的MM患者进行单中心观察性前瞻性研究,入组时均无ONJ。每3个月对患者进行随访,为期18个月,进行临床/牙科检查,并连续测量炎性细胞因子、骨转换标志物和血管生成生长因子。通过对唾液中16S rRNA基因进行测序来表征口腔微生物群。

结果

在研究期间,14例患者(13%)发生了BRONJ,从MM诊断起的中位时间为5.7年(95%CI:1.9 - 12.0)。慢性牙周病是主要的临床观察到的危险因素。口腔微生物谱分析显示BRONJ中的细菌丰富度/多样性较低。对照组中 、 和 丰富;BRONJ中 和 普遍存在。在唾液中,基线时发生BRONJ的患者与未发生BRONJ的患者相比,MIP - 1β、TNF - α和IL - 6水平更高,细胞因子谱与M - 1巨噬细胞活化一致。在血清中,BRONJ患者在研究期间TGFβ和VEGF水平显著降低。

结论

牙周病与微生物多样性低以及具有促炎细胞因子谱的侵袭性物种占主导有关,导致组织损伤和免疫改变,这似乎是BRONJ发病机制中的主要罪魁祸首。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5171/8263936/a3b5c1531643/fonc-11-704722-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5171/8263936/a8b3b38c1c3c/fonc-11-704722-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5171/8263936/a3b5c1531643/fonc-11-704722-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5171/8263936/a8b3b38c1c3c/fonc-11-704722-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5171/8263936/a3b5c1531643/fonc-11-704722-g002.jpg

相似文献

1
Prospective Observational Study of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma: Microbiota Profiling and Cytokine Expression.多发性骨髓瘤中双膦酸盐相关颌骨坏死的前瞻性观察研究:微生物群分析和细胞因子表达
Front Oncol. 2021 Jun 24;11:704722. doi: 10.3389/fonc.2021.704722. eCollection 2021.
2
Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw.口腔微生物群与双膦酸盐相关颌骨坏死中的宿主固有免疫反应。
Int J Oral Sci. 2014 Dec;6(4):219-26. doi: 10.1038/ijos.2014.46. Epub 2014 Aug 8.
3
Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.静脉注射双膦酸盐相关颌骨坏死:骨闪烁显像作为早期指标
J Oral Maxillofac Surg. 2009 Jul;67(7):1363-72. doi: 10.1016/j.joms.2009.03.005.
4
Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.双膦酸盐相关颌骨坏死(BRONJ)的治疗。一项批判性综述。
Minerva Stomatol. 2010 Apr;59(4):181-203, 204-13.
5
IL-17-mediated M1/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws.IL-17 介导的 M1/M2 巨噬细胞表型改变促进双膦酸盐相关性颌骨骨坏死的发病机制。
Clin Cancer Res. 2013 Jun 15;19(12):3176-88. doi: 10.1158/1078-0432.CCR-13-0042. Epub 2013 Apr 24.
6
Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.长期静脉注射双膦酸盐治疗停药后双膦酸盐相关颌骨坏死患者的骨转换和血管生成血清标志物
J Oral Maxillofac Surg. 2016 Apr;74(4):738-46. doi: 10.1016/j.joms.2015.09.028. Epub 2015 Oct 3.
7
Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate.瑞典颌骨坏死与口服双膦酸盐有关。
J Oral Maxillofac Surg. 2014 Jan;72(1):76-82. doi: 10.1016/j.joms.2013.06.221. Epub 2013 Aug 29.
8
Incidence and risk factors of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients having undergone autologous stem cell transplantation.接受自体干细胞移植的多发性骨髓瘤患者中双膦酸盐相关颌骨坏死的发生率及危险因素。
Onkologie. 2012;35(11):658-64. doi: 10.1159/000343950. Epub 2012 Oct 22.
9
Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw.牙周病作为双膦酸盐相关性颌骨骨坏死的一个风险因素。
J Periodontol. 2014 Feb;85(2):226-33. doi: 10.1902/jop.2013.130017. Epub 2013 Jun 20.
10
Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?颌骨骨坏死与非恶性疾病:与类风湿关节炎有关吗?
J Rheumatol. 2013 Jun;40(6):781-6. doi: 10.3899/jrheum.120810. Epub 2013 Mar 15.

引用本文的文献

1
Oral and Gingival Crevicular Fluid Biomarkers for Jawbone Turnover Diseases: A Scoping Review.用于颌骨周转疾病的口腔和龈沟液生物标志物:一项范围综述
Diagnostics (Basel). 2024 Sep 30;14(19):2184. doi: 10.3390/diagnostics14192184.
2
TGF-β: an active participant in the immune and metabolic microenvironment of multiple myeloma : TGF-β in the microenvironment of multiple myeloma.TGF-β:多发性骨髓瘤免疫和代谢微环境的积极参与者:多发性骨髓瘤微环境中的 TGF-β。
Ann Hematol. 2024 Nov;103(11):4351-4362. doi: 10.1007/s00277-024-05843-4. Epub 2024 Jun 20.
3
Can medication-related osteonecrosis of the jaw be attributed to specific microorganisms through oral microbiota analyses? A preliminary study.

本文引用的文献

1
Influence of the long-term use of oral hygiene products containing stannous ions on the salivary microbiome - a randomized controlled trial.长期使用含锡离子的口腔卫生产品对唾液微生物组的影响——一项随机对照试验。
Sci Rep. 2020 Jun 12;10(1):9546. doi: 10.1038/s41598-020-66412-z.
2
Zoledronate Inhibits Osteoclast Differentiation via Suppressing Vascular Endothelial Growth Factor Receptor 2 Expression.唑来膦酸通过抑制血管内皮生长因子受体 2 的表达抑制破骨细胞分化。
Biochem Genet. 2020 Jun;58(3):473-489. doi: 10.1007/s10528-020-09961-2. Epub 2020 Apr 9.
3
Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors.
药物相关性下颌骨坏死能否通过口腔微生物组分析归因于特定的微生物?一项初步研究。
BMC Oral Health. 2024 Feb 1;24(1):160. doi: 10.1186/s12903-024-03945-z.
4
Medication-Related Osteonecrosis of the Jaw: A Systematic Review and a Bioinformatic Analysis.药物相关性颌骨坏死:系统评价与生物信息学分析。
Int J Mol Sci. 2023 Nov 25;24(23):16745. doi: 10.3390/ijms242316745.
5
Are medication-induced salivary changes the culprit of osteonecrosis of the jaw? A systematic review.药物引起的唾液变化是颌骨坏死的罪魁祸首吗?一项系统评价。
Front Med (Lausanne). 2023 Aug 31;10:1164051. doi: 10.3389/fmed.2023.1164051. eCollection 2023.
6
[Latest Findings on the Mechanism of the Interaction Between Multiple Myeloma Cells and Bone Marrow Microenvironment].[多发性骨髓瘤细胞与骨髓微环境相互作用机制的最新研究发现]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 May;54(3):475-481. doi: 10.12182/20230560207.
7
Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ.唑来膦酸和地舒单抗在 Hu-BLT 模型中诱导牙龈 IFN-γ 严重抑制的情况下,骨髓来源免疫细胞对 IFN-γ 的增强作用。
Front Endocrinol (Lausanne). 2023 Jan 20;14:1111627. doi: 10.3389/fendo.2023.1111627. eCollection 2023.
8
Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications.多发性骨髓瘤中的肠道微生物组:进展机制和临床应用。
Front Immunol. 2022 Dec 8;13:1058272. doi: 10.3389/fimmu.2022.1058272. eCollection 2022.
9
The Dynamic Feature of Macrophage M1/M2 Imbalance Facilitates the Progression of Non-Traumatic Osteonecrosis of the Femoral Head.巨噬细胞M1/M2失衡的动态特征促进非创伤性股骨头坏死的进展。
Front Bioeng Biotechnol. 2022 Apr 27;10:912133. doi: 10.3389/fbioe.2022.912133. eCollection 2022.
通过预防性牙科护理和了解风险因素来减轻颌骨骨坏死(ONJ)。
Bone Res. 2020 Mar 11;8:14. doi: 10.1038/s41413-020-0088-1. eCollection 2020.
4
[Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates].[双膦酸盐所致颌骨坏死的机制、预防及治疗的基础研究]
Yakugaku Zasshi. 2020;140(1):63-79. doi: 10.1248/yakushi.19-00125.
5
Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ).颌骨骨坏死(ONJ)早期的黏膜下脉管系统变化。
Bone. 2019 Jun;123:234-245. doi: 10.1016/j.bone.2019.03.031. Epub 2019 Apr 3.
6
Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?慢性炎症性疾病中的巨噬细胞极化:杀手还是建设者?
J Immunol Res. 2018 Jan 14;2018:8917804. doi: 10.1155/2018/8917804. eCollection 2018.
7
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.地舒单抗对比唑来膦酸在初诊多发性骨髓瘤骨病治疗中的应用:一项国际性、双盲、双模拟、随机、对照、3 期研究。
Lancet Oncol. 2018 Mar;19(3):370-381. doi: 10.1016/S1470-2045(18)30072-X. Epub 2018 Feb 9.
8
Interventions for managing medication-related osteonecrosis of the jaw.颌骨药物相关性骨坏死的管理干预措施。
Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD012432. doi: 10.1002/14651858.CD012432.pub2.
9
Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab.接受双膦酸盐和地诺单抗序贯治疗的骨转移患者颌骨坏死的发生率。
Acta Clin Belg. 2018 Apr;73(2):100-109. doi: 10.1080/17843286.2017.1348001. Epub 2017 Jul 10.
10
Role of microbiological culture and polymerase chain reaction (PCR) of actinomyces in medication-related osteonecrosis of the jaw (MRONJ).放线菌的微生物培养和聚合酶链反应(PCR)在药物相关性颌骨坏死(MRONJ)中的作用。
J Craniomaxillofac Surg. 2017 Mar;45(3):357-363. doi: 10.1016/j.jcms.2017.01.006. Epub 2017 Jan 9.